Phillip McCarthy, MD, discusses autologous stem cell transplant/rescue following induction therapy, available therapies, and why a majority of patients will have progressive disease.
Created by
Related Presenters
Professor of Oncology and Internal Medicine
Director, Transplant & Cellular Therapy Center, Department of Medicine
My research interests are devoted to developing novel intensive and reduced intensity allogeneic and autologous hematopoietic stem cell transplant (HSCT) approaches for the treatment of hematologic disorders, leading to improved patient outcomes...
BROADCASTMED